189 related articles for article (PubMed ID: 18992253)
1. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
Bur D; Dale GE; Oefner C
Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
[TBL] [Abstract][Full Text] [Related]
3. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
Emoto N; Yanagisawa M
J Biol Chem; 1995 Jun; 270(25):15262-8. PubMed ID: 7797512
[TBL] [Abstract][Full Text] [Related]
5. In-silico characterization of ECE-1 inhibitors.
Ajay Babu P; Colluru VT; Anaparthy N
Comput Biol Med; 2012 Apr; 42(4):446-57. PubMed ID: 22245098
[TBL] [Abstract][Full Text] [Related]
6. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon.
Oefner C; D'Arcy A; Hennig M; Winkler FK; Dale GE
J Mol Biol; 2000 Feb; 296(2):341-9. PubMed ID: 10669592
[TBL] [Abstract][Full Text] [Related]
7. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.
Gagnidze K; Sachchidanand ; Rozenfeld R; Mezei M; Zhou MM; Devi LA
J Med Chem; 2008 Jun; 51(12):3378-87. PubMed ID: 18507370
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities.
Ul-Haq Z; Iqbal S; Moin ST
BMC Bioinformatics; 2012 Nov; 13():285. PubMed ID: 23113990
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.
Lin CL; Winardi W; Jeng AY; Kwan AL
Neurol Res; 2006 Oct; 28(7):721-9. PubMed ID: 17164035
[TBL] [Abstract][Full Text] [Related]
11. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
Ahn K; Herman SB; Fahnoe DC
Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-2-converting enzyme from human renal adenocarcinoma cells is a phosphoramidon-sensitive, membrane-bound metalloprotease.
Shinmi O; Yorimitsu K; Moroi K; Nishiyama M; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S61-4. PubMed ID: 7510000
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
Wallace EM; Moliterni JA; Moskal MA; Neubert AD; Marcopulos N; Stamford LB; Trapani AJ; Savage P; Chou M; Jeng AY
J Med Chem; 1998 Apr; 41(9):1513-23. PubMed ID: 9554884
[TBL] [Abstract][Full Text] [Related]
14. Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.
Shimada K; Takahashi M; Turner AJ; Tanzawa K
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):863-7. PubMed ID: 8645169
[TBL] [Abstract][Full Text] [Related]
15. Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells.
Fahnoe DC; Johnson GD; Herman SB; Ahn K
Arch Biochem Biophys; 2000 Jan; 373(2):385-93. PubMed ID: 10620363
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
Hoang MV; Sansom CE; Turner AJ
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells.
Azarani A; Boileau G; Crine P
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):439-48. PubMed ID: 9657986
[TBL] [Abstract][Full Text] [Related]
18. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin.
Johnson GD; Stevenson T; Ahn K
J Biol Chem; 1999 Feb; 274(7):4053-8. PubMed ID: 9933597
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-converting enzymes.
Opgenorth TJ; Wu-Wong JR; Shiosaki K
FASEB J; 1992 Jun; 6(9):2653-9. PubMed ID: 1612289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]